NASDAQ:LIFE - aTyr Pharma Stock Price, Forecast & News

aTyr Pharma trades on the NASDAQ under the ticker symbol "LIFE."

aTyr Pharma shares reverse split on Monday, July 1st 2019. The 1-14 reverse split was announced on Friday, June 28th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 28th 2019. An investor that had 100 shares of aTyr Pharma stock prior to the reverse split would have 7 shares after the split.

aTyr Pharma Inc (NASDAQ:LIFE) issued its earnings results on Thursday, November, 14th. The biotechnology company reported ($1.47) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($1.43) by $0.04. The biotechnology company earned $0.18 million during the quarter, compared to analyst estimates of $0.06 million. View aTyr Pharma's Earnings History.

aTyr Pharma is scheduled to release their next quarterly earnings announcement on Monday, March 23rd 2020. View Earnings Estimates for aTyr Pharma.

3 brokers have issued 12 month price targets for aTyr Pharma's stock. Their forecasts range from $4.00 to $8.00. On average, they anticipate aTyr Pharma's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 1.7% from the stock's current price. View Analyst Price Targets for aTyr Pharma.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for aTyr Pharma in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for aTyr Pharma.

News stories about LIFE stock have trended somewhat negative recently, InfoTrie reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. aTyr Pharma earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for aTyr Pharma.

aTyr Pharma saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 6,700 shares, an increase of 91.4% from the December 15th total of 3,500 shares. Based on an average daily trading volume, of 215,500 shares, the short-interest ratio is currently 0.0 days. Currently, 0.2% of the company's shares are sold short. View aTyr Pharma's Current Options Chain.

Some companies that are related to aTyr Pharma include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM) and Harvard Bioscience (HBIO).

Based on aggregate information from My MarketBeat watchlists, some companies that other aTyr Pharma investors own include Wynn Resorts (WYNN), Biocept (BIOC), Gilead Sciences (GILD), SCYNEXIS (SCYX), Viking Therapeutics (VKTX), Crispr Therapeutics (CRSP), Amicus Therapeutics (FOLD), QUALCOMM (QCOM), Rigel Pharmaceuticals (RIGL) and Idera Pharmaceuticals (IDRA).

(LIFE) raised $76 million in an initial public offering on Thursday, May 7th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Citigroup served as the underwriters for the IPO and BMO Capital Markets and William Blair were co-managers.

Shares of LIFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LIFE stock can currently be purchased for approximately $5.90.

aTyr Pharma has a market capitalization of $22.95 million. The biotechnology company earns $-34,510,000.00 in net income (profit) each year or ($16.11) on an earnings per share basis. aTyr Pharma employs 42 workers across the globe.View Additional Information About aTyr Pharma.

The official website for aTyr Pharma is http://www.atyrpharma.com/.

aTyr Pharma's mailing address is 3545 JOHN HOPKINS COURT SUITE 250, SAN DIEGO CA, 92121. The biotechnology company can be reached via phone at 858-731-8389 or via email at [email protected]